Pharmaceuticals, Biotechnology and Life Sciences
NAARDEN, The Netherlands and MIAMI, July 03, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or…
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF…
Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp.…
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…
— Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History — — Signed $30 Million in Net…
Dr. Malik to deepen strategic leadership and provide regulatory and clinical development innovation expertiseGAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE)…
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) — Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical…
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team…
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing…
TORONTO, July 02, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…